Akeso has a validated process in place for developing antibodies but does require US exposure to meet its lofty valuation.

Pfizer beats Q3 estimates, raises FY guidance, acquires Metsera for obesity drugs, and offers a 7% yield. Read here for an ...

US pharma giant Pfizer has provided a reminder of the merits of mRNA-based vaccines as health leaders in the USA continue to question their safety.

BMO's new CDRs will trade under the following tickers: Company Name and Type of Shares CDR Ticker Jurisdiction Apple Inc. Common Shares ZAAP U.S. Intel Corporation Common Shares ZINT U.S. Mastercard ...

Agreement includes license to Nona's fully human HCAb platform for preclinical antibody discovery CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company ...

With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

Pfizer Inc. has announced the successful completion of its acquisition of Metsera, Inc., a clinical-stage biopharmaceutical ...

The ASX healthcare sector ended the week ending November 21, 2025 down, following a sharp sell-off as on Wall Street and ...

Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage ...

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

Vaccinations have been completed and Valneva expects VALOR trial outcomes to be announced in the first half of 2026, followed by regulatory submissions as planned. Pfizer aims to submit a Biologics ...

Craig Faller previously led the U.S. Southern Command, while Adele Gulfo served as CEO of Sumitomo Pharma America's biopharma commercial unit.